D. Duro

发表

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, The Lancet Neurology.

APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.

I. Santana, B. Oliveiros, C. Lemos, 2020, Journal of Alzheimer's disease : JAD.

Face-Specific Perceptual Distortions Reveal A View- and Orientation-Independent Face Template

Sarah B. Herald, B. Duchaine, Q. Bukhari, 2020, Current Biology.

White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, NeuroImage: Clinical.

Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia

I. Santana, I. Baldeiras, B. Santiago, 2019, Diagnostics.

Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.

I. Santana, C. Oliveira, I. Baldeiras, 2008, Journal of Alzheimer's disease : JAD.

Oxidative damage and mitochondrial dysfunction in patients with mild cognitive impairment and Alzheimer's disease

I. Santana, I. Baldeiras, C. Oliveira, 2010, Alzheimer's & Dementia.

Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.

I. Santana, C. Oliveira, I. Baldeiras, 2010, Journal of Alzheimer's disease : JAD.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Jennifer M. Nicholas, P. Thompson, R. Keren, 2022, Journal of Neurology.

The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia

Nick C Fox, M. Freedman, S. Ourselin, 2022, Annals of clinical and translational neurology.

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Jennifer M. Nicholas, Sheng-Yang M. Goh, M. Freedman, 2022, Nature Medicine.

[Mini-Mental State Examination: Screening and Diagnosis of Cognitive Decline, Using New Normative Data].

V. Costa, Raquel Lemos, M. Simões, 2016, Acta medica portuguesa.

DEPDC5 variant in focal cortical dysplasia: a case report and review of the literature

A. Freire, J. Melo, D. Duro, 2021, Oxford medical case reports.

Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study

Jennifer M. Nicholas, M. Freedman, N. Fox, 2021, Alzheimer's & dementia.

Genetic Variation of MT-ND Genes in Frontotemporal Lobar Degeneration: Biochemical Phenotype-Genotype Correlation

I. Santana, M. Grazina, D. Duro, 2015, Neurodegenerative Diseases.

Associations between self-reported sleep quality and cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease.

I. Baldeiras, D. Duro, M. J. Leitão, 2023, Revue neurologique.

Patients with progranulin mutations overlap with the progressive dysexecutive syndrome: towards the definition of a frontoparietal dementia phenotype

R. Guerreiro, I. Santana, I. Baldeiras, 2020, Brain communications.

Increased CSF tau is associated with a higher risk of seizures in patients with Alzheimer's disease

I. Santana, I. Baldeiras, M. R. Almeida, 2019, Epilepsy & Behavior.

Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.

M. Castelo‐Branco, I. Santana, Raquel Lemos, 2019, Journal of Alzheimer's disease : JAD.

The Head Turning Sign in Dementia and Mild Cognitive Impairment: Its Relationship to Cognition, Behavior, and Cerebrospinal Fluid Biomarkers

I. Santana, I. Baldeiras, B. Santiago, 2018, Dementia and Geriatric Cognitive Disorders.

Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.

I. Santana, S. Freitas, I. Baldeiras, 2018, Journal of Alzheimer's disease : JAD.

Prognosis of Early-Onset vs. Late-Onset Mild Cognitive Impairment: Comparison of Conversion Rates and Its Predictors

Isabel Santana, Beatriz Santiago, I. Santana, 2016, Geriatrics.

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

I. Santana, Raquel Lemos, C. Oliveira, 2015, Journal of the Neurological Sciences.

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, Brain : a journal of neurology.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, Neurobiology of Aging.

Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

M. Freedman, J. Dukart, R. Keren, 2023, Neurobiology of Disease.

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, NeuroImage: Clinical.

Montreal Cognitive Assessment (MoCA): Validation study for Frontotemporal Dementia

I. Santana, M. Simões, S. Freitas, 2012, Journal of geriatric psychiatry and neurology.

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

I. Santana, I. Baldeiras, C. Oliveira, 2018, Alzheimer's research & therapy.

Validation study of the Alzheimer’s disease assessment scale–cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer’s disease

I. Santana, S. Freitas, D. Duro, 2018, The Clinical neuropsychologist.

Clock drawing test in mild cognitive impairment: Correlation with cerebral perfusion in single-photon emission computed tomography.

I. Santana, M. J. Cunha, B. Santiago, 2019, Neuropsychology.

MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease

I. Santana, A. L. Cardoso, M. C. D. de Lima, 2015, Alzheimer's & dementia.

Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis

Isabel Santana, Mário R. Simões, I. Santana, 2010, Journal of Neurology.

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease

P. Lewczuk, J. Kornhuber, I. Santana, 2019, Alzheimer's Research & Therapy.

Validation Study of the Toulouse-Piéron Cancellation Test for Portuguese Patients with Mild Cognitive Impairment and Alzheimer ’ s Disease

I. Santana, M. Simões, S. Freitas, 2019 .

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

J. E. Iglesias, Jennifer M. Nicholas, M. Freedman, 2023, Brain communications.

Differential early subcortical involvement in genetic FTD within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, NeuroImage: Clinical.

C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia

I. Santana, I. Baldeiras, M. R. Almeida, 2020, Experimental Gerontology.

Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population.

M. Guerreiro, I. Santana, S. Freitas, 2018, Acta medica portuguesa.

normativo para a população portuguesa Alzheimer ’ s Disease Assessment Scale – Cognitive subscale ( ADAS-Cog ) : Normative data for the Portuguese population Autores :

I. Santana, S. Freitas, Manuela, 2018 .

Multiple Dural Arteriovenous Fistulas Presenting as Rapidly Progressive Dementia

I. Santana, A. Goulão, N. Mendonça, 2012, The neurologist.

Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia

I. Santana, I. Baldeiras, D. Duro, 2023, European journal of neurology.

The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease.

I. Santana, Raquel Lemos, M. Simões, 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Rare variants in TP73 in a frontotemporal dementia cohort link this gene with primary progressive aphasia phenotypes

R. Guerreiro, J. Bras, I. Santana, 2022, European journal of neurology.

Toulouse-Piéron Cancellation Test: Normative scores for the portuguese population

I. Santana, M. Simões, S. Freitas, 2021, Applied neuropsychology. Adult.

Discriminative capacity and construct validity of the Clock Drawing Test in Mild Cognitive Impairment and Alzheimer’s disease

I. Santana, S. Freitas, B. Santiago, 2018, The Clinical neuropsychologist.

Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population.

M. Guerreiro, I. Santana, S. Freitas, 2018, Acta medica portuguesa.

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Jennifer M. Nicholas, M. Freedman, S. Ourselin, 2021, Molecular Neurodegeneration.

Cerebrospinal fluid biomarkers in frontotemporal lobar degeneration

I. Santana, Raquel Lemos, I. Baldeiras, 2011 .

Lewy body dementia is associated with an increased risk of atrial fibrillation: A case-control study

I. Santana, I. Baldeiras, D. Duro, 2022, Journal of Clinical Neuroscience.

Theme 08 - Clinical Imaging and Electrophysiology

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

The Clock Drawing Test: Portuguese norms, by age and education, for three different scoring systems.

I. Santana, M. Simões, S. Freitas, 2013, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Validity and Clinical Utility of Different Clock Drawing Test Scoring Systems in Multiple Forms of Dementia

I. Santana, S. Freitas, B. Santiago, 2018, Journal of geriatric psychiatry and neurology.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

I. Santana, I. Baldeiras, C. Oliveira, 2018, Alzheimer's Research & Therapy.

Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

Jennifer M. Nicholas, M. Freedman, R. Keren, 2023, Journal of the Neurological Sciences.

Montreal Cognitive Assessment (MoCA): Validation study for Frontotemporal Dementia

I. Santana, M. Simões, L. Alves, 2012, Journal of geriatric psychiatry and neurology.

Frontotemporal dementia: neuroanatomical correlates of an atypical presentation

I. Santana, L. Letra, D. Duro, 2014, BMJ Case Reports.

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

I. Santana, Raquel Lemos, C. Oliveira, 2015, Journal of the Neurological Sciences.

Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

Y. Pijnenburg, T. Rittman, B. Nacmias, 2024, Alzheimer's Research & Therapy.

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

A. Danek, Y. Pijnenburg, R. Vandenberghe, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.